YCBD
YCBD
AMEX · Pharmaceuticals

Cbdmd Inc

$0.67
-0.02 (-3.49%)
As of Jun 23, 10:15 PM ET ·
Financial Highlights (FY 2026)
Revenue
50.08M
Net Income
-5,326,642
Gross Margin
62.4%
Profit Margin
-10.6%
Rev Growth
-18.5%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.4% 62.4% 47.5% 47.5%
Operating Margin -11.3% -10.1% 13.5% 15.0%
Profit Margin -10.6% -10.1% 12.2% 13.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 50.08M 61.42M 3.60M 4.26M
Gross Profit 31.24M 38.31M 1.71M 2.02M
Operating Income -5,644,169 -6,229,767 486.9K 638.9K
Net Income -5,326,642 -5,879,295 438.1K 574.3K
Gross Margin 62.4% 62.4% 47.5% 47.5%
Operating Margin -11.3% -10.1% 13.5% 15.0%
Profit Margin -10.6% -10.1% 12.2% 13.5%
Rev Growth -18.5% -18.5% +16.0% +23.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.68M 3.44M
Total Equity 4.26M 4.18M
D/E Ratio 0.63 0.82
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -2,705,313 -3,151,885 810.0K 832.9K
Free Cash Flow 302.1K 332.0K